Article
Midnolin is a confirmed genetic risk factor for Parkinson’s disease
6 Oct 2019
Abstract excerpt
Abstract Objective Genetic analysis of patients with familial Parkinson’s disease (PD) identified many causative genes. However, the majority of PD cases are sporadic, and the mechanisms of onset still remain unclear. Previously, we found that Midnolin (MIDN) is associated with PD in a Yamagata (Japan) cohort study and that MIDN regulates neurite outgrowth and Parkin expression in neuronal cells. In the present...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
